The tobacco group said that it was designed to support Vectura’s “scientific efforts”, but did not provide further details. Philip Morris also reiterated that Vectura would operate as “an autonomous business unit forming the backbone of its inhaled therapeutics business”. The reference to the governance structure for scientists comes amid concerns from public health bodies that Vectura would be weakened by Philip Morris because of restrictions on the operations of tobacco companies. The update was made alongside the issue of its offer document to Vectura’s shareholders. Philip Morris said also said that

Source: The Times August 16, 2021 23:02 UTC